By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


EpiCept Corporation (Merged With Immune Pharmaceuticals) 

150 Broadway
Suite 1801
Tarrytown  New York  10591  U.S.A.
Phone: 646-937-1941 Fax: n/a



Drug Delivery

Company News
Immune Pharmaceuticals Completes Merger With EpiCept Corporation 8/26/2013 9:41:29 AM
EpiCept Corporation (Merged With Immune Pharmaceuticals) (EPCT) Announces Reverse Stock Split and Change of Corporate Name to Immune Pharmaceuticals 8/20/2013 9:18:45 AM
EpiCept Corporation (EPCT) Stockholders Overwhelmingly Approve Final Conditions to Merger With Immune Pharmaceuticals 8/8/2013 9:36:26 AM
EpiCept Corporation (EPCT) Reports Second Quarter 2013 Operating and Financial Results 8/1/2013 6:39:45 AM
EpiCept Corporation (EPCT) Issues Notice of Special Meeting of Stockholders on August 6 to Approve Important Aspects of the Proposed Merger With Immune Pharmaceuticals 6/20/2013 8:50:22 AM
EpiCept Corporation (EPCT) Announces New Crolibulin Data Presented at American Society of Clinical Oncology 2013 Support Further Evaluation in Anaplastic Thyroid Cancer 6/3/2013 10:14:46 AM
EpiCept Corporation (EPCT) Reports First Quarter 2013 Operating and Financial Results 5/20/2013 9:59:05 AM
EpiCept Corporation (EPCT) Reports Fourth Quarter and Full Year 2012 Operating and Financial Results 2/28/2013 6:18:11 AM
EpiCept Corporation (EPCT) to Present at the 15th Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/7/2013 6:38:38 AM
EpiCept Corporation (EPCT) Reports Total Shares Outstanding 2/1/2013 8:57:23 AM